Financhill
Back

Hypera SA 10K Form

Sell
44

HYPMY
Hypera SA

Last Price:
$4.53
Seasonality Move:
2.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HYPMY News And Ratings

See the #1 stock for the next 7 days that we like better than HYPMY

HYPMY Financial Statistics

Sales & Book Value

Annual Sales: $1.4B
Cash Flow: $92.2M
Price / Cash Flow: 27.77
Annual Sales: $3.64
Price / Book: 1.29

Profitability

EPS (TTM): 0.23330
Net Income (TTM): $148.4M
Gross Margin: $780.3M
Return on Equity: 6.9%
Return on Assets: 2.97%

Hypera SA Earnings Forecast

Key Hypera SA Financial Ratios

  • The Gross Profit Margin over the past 20 years for HYPMY is 56.52%.
  • The Selling, General & Administrative Expenses for HYPMY have been equal to 35.66% of Gross Profit Margin.
  • The Research & Development expenses have been 1.96% of Revenue.
  • The Interest Expense is 78.19% of Operating Income.
  • The Net Earning history of HYPMY is 17.91% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 7 years.

Hypera SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HYPMY
Website: hypera.com.br

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 1.27
Quick Ratio: 0.7

Price-to-Earnings

Trailing P/E Ratio: 12.03
Forward P/E Ratio: 0

HYPMY Technical Analysis vs Fundamental Analysis

Sell
44
Hypera SA (HYPMY) is a Sell

Is Hypera SA a Buy or a Sell?

  • Hypera SA stock is rated a Sell
    The current Hypera SA [HYPMY] share price is $4.69. The Score for HYPMY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.